Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control

BACKGROUND: It is unclear whether people with type 2 diabetes mellitus on insulin monotherapy who do not achieve adequate glycaemic control should continue insulin as monotherapy or can benefit from adding oral glucose‐lowering agents to the insulin therapy. OBJECTIVES: To assess the effects of insu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cochrane Database Syst Rev
Main Authors: Vos, Rimke C, van Avendonk, Mariëlle JP, Jansen, Hanneke, Goudswaard, Alexander Nicolaas N, van den Donk, Maureen, Gorter, Kees, Kerssen, Anneloes, Rutten, Guy EHM
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2016
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6457595/
https://ncbi.nlm.nih.gov/pubmed/27640062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006992.pub2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki